Abstract
This secondary analysis of a randomized clinical trial investigates the effect of spironolactone and cyproterone acetate hormone therapy on the QT interval corrected for heart rate among transgender women and nonbinary or transfeminine individuals.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have